Detalhe da pesquisa
1.
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common ß-chain cytokine receptor endocytosis.
Blood
; 139(5): 761-778, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780648
2.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
3.
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.
Haematologica
; 109(2): 401-410, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534515
4.
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.
Haematologica
; 108(6): 1567-1578, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727397
5.
Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia.
Haematologica
; 107(11): 2641-2649, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511672
6.
A graphical, interactive and GPU-enabled workflow to process long-read sequencing data.
BMC Genomics
; 22(1): 626, 2021 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34425749
7.
Capillary-Mediated Single-Cell Dispenser.
Anal Chem
; 93(31): 10750-10755, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34319086
8.
Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries.
Cost Eff Resour Alloc
; 19(1): 18, 2021 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712039
9.
Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia.
J Oncol Pharm Pract
; 27(8): 1842-1852, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33175653
10.
Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 26(7): 1371-1374, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32194289
11.
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
N Engl J Med
; 376(10): 917-927, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273028
12.
Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies.
Blood
; 131(25): 2782-2788, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29618479
13.
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.
Am J Hematol
; 95(1): 48-56, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31637757
14.
A Fluorescence-Activated Single-Droplet Dispenser for High Accuracy Single-Droplet and Single-Cell Sorting and Dispensing.
Anal Chem
; 91(10): 6815-6819, 2019 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050286
15.
Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis.
Blood
; 130(1): 48-58, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490572
16.
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.
Hematol Oncol
; 37(3): 240-252, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013548
17.
The (near) miracle of therapy in chronic myeloid leukaemia.
Br J Haematol
; 202(5): 919-921, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37495373
18.
Sequencing small genomic targets with high efficiency and extreme accuracy.
Nat Methods
; 12(5): 423-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849638
19.
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network.
Haematologica
; 108(11): 3148-3151, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021537
20.
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.
BMC Cancer
; 18(1): 359, 2018 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29609532